Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Arthritis of the first metatarsophalangeal joint is not always gout: a prospective cohort study in primary care patients.

Kienhorst LB, Janssens HJ, Fransen J, van de Lisdonk EH, Janssen M.

Joint Bone Spine. 2014 Jul;81(4):342-6. doi: 10.1016/j.jbspin.2013.12.001. Epub 2014 Jan 24.

PMID:
24468668
2.

Vascular outcomes in patients with screen-detected or clinically diagnosed type 2 diabetes: Diabscreen study follow-up.

Klein Woolthuis EP, de Grauw WJ, van Keeken SM, Akkermans RP, van de Lisdonk EH, Metsemakers JF, van Weel C.

Ann Fam Med. 2013 Jan-Feb;11(1):20-7. doi: 10.1370/afm.1460.

3.

A case-control study of determinants for the occurrence of gouty arthritis in heart failure patients.

Hueskes BA, Willems FF, Leen AC, Ninaber PA, Westra R, Mantel-Teeuwisse AK, Janssens HJ, van de Lisdonk EH, Roovers EA, Janssen M.

Eur J Heart Fail. 2012 Aug;14(8):916-21. doi: 10.1093/eurjhf/hfs086. Epub 2012 Jun 21.

4.

Use of diuretics and the risk of gouty arthritis: a systematic review.

Hueskes BA, Roovers EA, Mantel-Teeuwisse AK, Janssens HJ, van de Lisdonk EH, Janssen M.

Semin Arthritis Rheum. 2012 Jun;41(6):879-89. doi: 10.1016/j.semarthrit.2011.11.008. Epub 2012 Jan 4. Review.

PMID:
22221907
5.

[Aftercare in oncology--greater role for the general practitioner].

de Vegt F, van Dijck JA, van de Lisdonk EH, Verbeek AL.

Ned Tijdschr Geneeskd. 2011;155(45):A4148. Dutch.

PMID:
22085581
6.

[The patient with arthritis: care by both general practitioners and rheumatologists].

Janssens H, van de Lisdonk EH, Janssen M.

Ned Tijdschr Geneeskd. 2011;155(30-31):A3539. Dutch.

PMID:
22085517
7.

Measurement invariance with respect to ethnicity of the Patient Health Questionnaire-9 (PHQ-9).

Baas KD, Cramer AO, Koeter MW, van de Lisdonk EH, van Weert HC, Schene AH.

J Affect Disord. 2011 Mar;129(1-3):229-35. doi: 10.1016/j.jad.2010.08.026.

PMID:
20888647
8.

A diagnostic rule for acute gouty arthritis in primary care without joint fluid analysis.

Janssens HJ, Fransen J, van de Lisdonk EH, van Riel PL, van Weel C, Janssen M.

Arch Intern Med. 2010 Jul 12;170(13):1120-6. doi: 10.1001/archinternmed.2010.196.

PMID:
20625017
9.

Limited validity of the American College of Rheumatology criteria for classifying patients with gout in primary care.

Janssens HJ, Janssen M, van de Lisdonk EH, Fransen J, van Riel PL, van Weel C.

Ann Rheum Dis. 2010 Jun;69(6):1255-6. doi: 10.1136/ard.2009.123687. Epub 2009 Nov 11. No abstract available.

PMID:
19910298
10.

Yield of opportunistic targeted screening for type 2 diabetes in primary care: the diabscreen study.

Klein Woolthuis EP, de Grauw WJ, van Gerwen WH, van den Hoogen HJ, van de Lisdonk EH, Metsemakers JF, van Weel C.

Ann Fam Med. 2009 Sep-Oct;7(5):422-30. doi: 10.1370/afm.997.

11.

The effect on caregiver burden of a problem-based home visiting programme for frail older people.

Melis RJ, van Eijken MI, van Achterberg T, Teerenstra S, Vernooij-Dassen MJ, van de Lisdonk EH, Rikkert MG.

Age Ageing. 2009 Sep;38(5):542-7. doi: 10.1093/ageing/afp101. Epub 2009 Jul 2.

PMID:
19574322
12.

Prevalence of zebras in general practice: data from the Continuous Morbidity Registration Nijmegen.

van de Laar FA, Bor H, van de Lisdonk EH.

Eur J Gen Pract. 2008;14 Suppl 1:44-6. doi: 10.1080/13814780802436176.

PMID:
18949644
13.

Multimorbidity in primary care: prevalence and trend over the last 20 years.

Uijen AA, van de Lisdonk EH.

Eur J Gen Pract. 2008;14 Suppl 1:28-32. doi: 10.1080/13814780802436093.

PMID:
18949641
14.

Screening for type 2 diabetes in primary care using a stepwise protocol: the Diabscreen study.

Klein Woolthuis EP, de Grauw WJ, van Gerwen WH, van den Hoogen HJ, van de Lisdonk EH, Metsemakers JF, van Weel C.

Prim Care Diabetes. 2007 Dec;1(4):199-202. doi: 10.1016/j.pcd.2007.09.002. Epub 2007 Oct 30.

PMID:
18632046
15.

Setting and registry characteristics affect the prevalence and nature of multimorbidity in the elderly.

Schram MT, Frijters D, van de Lisdonk EH, Ploemacher J, de Craen AJ, de Waal MW, van Rooij FJ, Heeringa J, Hofman A, Deeg DJ, Schellevis FG.

J Clin Epidemiol. 2008 Nov;61(11):1104-12. doi: 10.1016/j.jclinepi.2007.11.021. Epub 2008 Jun 6.

PMID:
18538993
16.

Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial.

Janssens HJ, Janssen M, van de Lisdonk EH, van Riel PL, van Weel C.

Lancet. 2008 May 31;371(9627):1854-60. doi: 10.1016/S0140-6736(08)60799-0.

PMID:
18514729
17.

Systemic corticosteroids for acute gout.

Janssens HJ, Lucassen PL, Van de Laar FA, Janssen M, Van de Lisdonk EH.

Cochrane Database Syst Rev. 2008 Apr 16;(2):CD005521. doi: 10.1002/14651858.CD005521.pub2. Review.

PMID:
18425920
18.

A randomized study of a multidisciplinary program to intervene on geriatric syndromes in vulnerable older people who live at home (Dutch EASYcare Study).

Melis RJ, van Eijken MI, Teerenstra S, van Achterberg T, Parker SG, Borm GF, van de Lisdonk EH, Wensing M, Rikkert MG.

J Gerontol A Biol Sci Med Sci. 2008 Mar;63(3):283-90.

PMID:
18375877
19.

Cost-effectiveness of a multidisciplinary intervention model for community-dwelling frail older people.

Melis RJ, Adang E, Teerenstra S, van Eijken MI, Wimo A, van Achterberg T, van de Lisdonk EH, Rikkert MG.

J Gerontol A Biol Sci Med Sci. 2008 Mar;63(3):275-82.

PMID:
18375876
20.

Prognosis and vascular co-morbidity in dementia a historical cohort study in general practice.

Meerman L, van de Lisdonk EH, Koopmans RT, Zielhuis GA, Olde Rikkert MG.

J Nutr Health Aging. 2008 Feb;12(2):145-50.

PMID:
18264643
21.

The role of craving in relapse after discontinuation of long-term benzodiazepine use.

Mol AJ, Oude Voshaar RC, Gorgels WJ, Breteler MH, van Balkom AJ, van de Lisdonk EH, Kan CC, Zitman FG.

J Clin Psychiatry. 2007 Dec;68(12):1894-900.

PMID:
18162020
22.

Consequences of a benzodiazepine discontinuation programme in family practice on psychotropic medication prescription to the participants.

Gorgels WJ, Oude Voshaar RC, Mol AJ, van de Lisdonk EH, Mulder J, van den Hoogen H, van Balkom AJ, Breteler MH, Zitman FG.

Fam Pract. 2007 Oct;24(5):504-10. Epub 2007 Jul 21.

PMID:
17644828
23.

Identifying people at risk for undiagnosed type 2 diabetes using the GP's electronic medical record.

Klein Woolthuis EP, de Grauw WJ, van Gerwen WH, van den Hoogen HJ, van de Lisdonk EH, Metsemakers JF, van Weel C.

Fam Pract. 2007 Jun;24(3):230-6. Epub 2007 May 16.

PMID:
17510087
24.

[Gout not induced by diuretics in a case-control study in general practice].

Janssens HJ, van de Lisdonk EH, Janssen M, van den Hoogen HJ, Verbeek AL.

Ned Tijdschr Geneeskd. 2007 Feb 24;151(8):472-7. Dutch.

PMID:
17378304
25.

Alpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose.

Van de Laar FA, Lucassen PL, Akkermans RP, Van de Lisdonk EH, De Grauw WJ.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD005061. Review. Update in: Cochrane Database Syst Rev. 2018 Dec 28;12:CD005061.

PMID:
17054235
26.

Eating behaviour and adherence to diet in patients with Type 2 diabetes mellitus.

van de Laar FA, van de Lisdonk EH, Lucassen PL, Stafleu A, Mulder J, van den Hoogen HJ, Rutten GE, van Weel C.

Diabet Med. 2006 Jul;23(7):788-94.

PMID:
16842485
27.

Predictors of long-term benzodiazepine abstinence in participants of a randomized controlled benzodiazepine withdrawal program.

Voshaar RC, Gorgels WJ, Mol AJ, van Balkom AJ, Mulder J, van de Lisdonk EH, Breteler MH, Zitman FG.

Can J Psychiatry. 2006 Jun;51(7):445-52.

PMID:
16838826
28.

Tapering off benzodiazepines in long-term users: an economic evaluation.

Oude Voshaar RC, Krabbe PF, Gorgels WJ, Adang EM, van Balkom AJ, van de Lisdonk EH, Zitman FG.

Pharmacoeconomics. 2006;24(7):683-94.

PMID:
16802844
29.

Long-term outcome of two forms of randomised benzodiazepine discontinuation.

Oude Voshaar RC, Gorgels WJ, Mol AJ, van Balkom AJ, Mulder J, van de Lisdonk EH, Breteler MH, Zitman FG.

Br J Psychiatry. 2006 Feb;188:188-9.

PMID:
16449709
30.

Gout, not induced by diuretics? A case-control study from primary care.

Janssens HJ, van de Lisdonk EH, Janssen M, van den Hoogen HJ, Verbeek AL.

Ann Rheum Dis. 2006 Aug;65(8):1080-3. Epub 2005 Nov 16.

31.

The design of the Dutch EASYcare study: a randomised controlled trial on the effectiveness of a problem-based community intervention model for frail elderly people [NCT00105378].

Melis RJ, van Eijken MI, Borm GF, Wensing M, Adang E, van de Lisdonk EH, van Achterberg T, Olde Rikkert MG.

BMC Health Serv Res. 2005 Oct 5;5:65.

32.

[Adenotonsillectomy in children only under exceptional circumstances].

van den Bosch WJ, van de Lisdonk EH.

Ned Tijdschr Geneeskd. 2005 Sep 10;149(37):2035-6. Dutch.

PMID:
16184943
33.

Associations of benzodiazepine craving with other clinical variables in a population of general practice patients.

Mol AJ, Gorgels WJ, Oude Voshaar RC, Breteler MH, van Balkom AJ, van de Lisdonk EH, Kan CC, Zitman FG.

Compr Psychiatry. 2005 Sep-Oct;46(5):353-60.

PMID:
16122535
34.

Appropriateness of benzodiazepine prescribing in general practice.

van Rijswijk E, Zandstra SM, van de Lisdonk EH, Zitman FG, van Weel C.

Int J Clin Pharmacol Ther. 2005 Aug;43(8):411-2. No abstract available.

PMID:
16119517
35.

Predictors of discontinuation of benzodiazepine prescription after sending a letter to long-term benzodiazepine users in family practice.

Gorgels WJ, Oude Voshaar RC, Mol AJ, van de Lisdonk EH, van Balkom AJ, Breteler MH, van den Hoogen HJ, Mulder J, Zitman FG.

Fam Pract. 2006 Feb;23(1):65-72. Epub 2005 Aug 17.

PMID:
16107495
36.

Changes in patients' attitudes towards the management of minor ailments.

Cardol M, Schellevis FG, Spreeuwenberg P, van de Lisdonk EH.

Br J Gen Pract. 2005 Jul;55(516):516-21. Erratum in: Br J Gen Pract. 2005 Aug;55(517):638.

37.

The absence of benzodiazepine craving in a general practice benzodiazepine discontinuation trial.

Mol AJ, Oude Voshaar RC, Gorgels WJ, Breteler MH, van Balkom AJ, van de Lisdonk EH, Kan CC, Mulder J, Zitman FG.

Addict Behav. 2006 Feb;31(2):211-22. Epub 2005 Jun 13.

PMID:
15951127
38.

A widening health gap in general practice? Socio-economic differences in morbidity between 1975 and 2000 in The Netherlands.

Mol GD, van de Lisdonk EH, Smits JP, van den Hoogen JM, Bor JH, Westert GP.

Public Health. 2005 Jul;119(7):616-25.

PMID:
15925677
39.

Alpha-glucosidase inhibitors for type 2 diabetes mellitus.

Van de Laar FA, Lucassen PL, Akkermans RP, Van de Lisdonk EH, Rutten GE, Van Weel C.

Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003639. Review.

PMID:
15846673
40.

Discontinuation of long-term benzodiazepine use by sending a letter to users in family practice: a prospective controlled intervention study.

Gorgels WJ, Oude Voshaar RC, Mol AJ, van de Lisdonk EH, van Balkom AJ, van den Hoogen HJ, Mulder J, Breteler MH, Zitman FG.

Drug Alcohol Depend. 2005 Apr 4;78(1):49-56.

PMID:
15769557
41.

Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis.

van de Laar FA, Lucassen PL, Akkermans RP, van de Lisdonk EH, Rutten GE, van Weel C.

Diabetes Care. 2005 Jan;28(1):154-63.

PMID:
15616251
42.

Chronic functional somatic symptoms: a single syndrome?

olde Hartman TC, Lucassen PL, van de Lisdonk EH, Bor HH, van Weel C.

Br J Gen Pract. 2004 Dec;54(509):922-7.

43.

Risk factors for development of impaired renal function in Type 2 diabetes mellitus patients in primary care.

Naushahi MJ, de Grauw WJ, Avery AJ, van Gerwen WH, van de Lisdonk EH, van Weel C.

Diabet Med. 2004 Oct;21(10):1096-101.

PMID:
15384956
44.

Long-term benzodiazepine users in family practice: differences from short-term users in mental health, coping behaviour and psychological characteristics.

Zandstra SM, Van Rijswijk E, Rijnders CA, Van De Lisdonk EH, Bor JH, Van Weel C, Zitman FG.

Fam Pract. 2004 Jun;21(3):266-9.

PMID:
15128687
45.

[The practice guideline 'Acute cough' from the Dutch College of General Practitioners; a response from the perspective of general practice].

van de Lisdonk EH, van den Bosch WJ.

Ned Tijdschr Geneeskd. 2004 Apr 10;148(15):700-2. Dutch.

PMID:
15119200
46.

Fat intake in patients newly diagnosed with type 2 diabetes: a 4-year follow-up study in general practice.

van de Laar FA, van de Lisdonk EH, Lucassen PL, Tigchelaar JM, Meyboom S, Mulder J, van den Hoogen HJ, Rutten GE, van Weel C.

Br J Gen Pract. 2004 Mar;54(500):177-82.

47.

Is acarbose equivalent to tolbutamide as first treatment for newly diagnosed type 2 diabetes in general practice? A randomised controlled trial.

van de Laar FA, Lucassen PL, Kemp J, van de Lisdonk EH, van Weel C, Rutten GE.

Diabetes Res Clin Pract. 2004 Jan;63(1):57-65.

PMID:
14693413
48.

Gout, just a nasty event or a cardiovascular signal? A study from primary care.

Janssens HJ, van de Lisdonk EH, Bor H, van den Hoogen HJ, Janssen M.

Fam Pract. 2003 Aug;20(4):413-6.

PMID:
12876112
49.

Development and psychometric evaluation of the Benzodiazepine Craving Questionnaire.

Mol AJ, Voshaar RC, Gorgels WJ, Breteler MH, van Balkom AJ, van de Lisdonk EH, van der Ven AH, Zitman FG.

Addiction. 2003 Aug;98(8):1143-52.

PMID:
12873249
50.

Tapering off long-term benzodiazepine use with or without group cognitive-behavioural therapy: three-condition, randomised controlled trial.

Voshaar RC, Gorgels WJ, Mol AJ, van Balkom AJ, van de Lisdonk EH, Breteler MH, van den Hoogen HJ, Zitman FG.

Br J Psychiatry. 2003 Jun;182:498-504.

PMID:
12777340

Supplemental Content

Loading ...
Support Center